Completion of Extinguishment of 4,70,000 fully paid-up equity shares of face value of INR 5 each pursuant to buyback of Windlas Biotech Limited (the 'Company') in accordance with Regulation ....
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Limited has completed the extinguishment of 4,70,000 equity shares (2.23% of pre-buyback capital) bought back through a tender offer. The buyback was conducted at INR 1,000 per share, totaling approximately INR 47 crore. Shares with face value of INR 5 each were accepted on a proportionate basis from eligible shareholders. Post-buyback, the company's paid-up capital reduced from 2,11,06,229 shares to 2,06,36,229 shares. The buyback was executed in dematerialized form only, with NSDL confirming the extinguishment on May 18, 2026.
This buyback at INR 1,000 per share (200x the face value) represents an extremely attractive exit for selling shareholders and signals management confidence in the company's intrinsic value. The reduction in share count will improve per-share metrics like EPS. Promoter holding increased from 61.90% to 63.31% post-buyback, consolidating control.